Suchergebnisse - "Jin, Yinzhu"

PubPharm (7)

1

Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis : a cross-national study

enthalten in: Clinical rheumatology | 2023

von Ingrasciotta, Y. | Jin, Y. | Foti, S. | +5

2

Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis

enthalten in: Arthritis care & research | 2022

von Jin, Y. | Lee, H. | Lee, M. | +4

3

Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA : A Cohort Study from Longitudinal Electronic Health Records

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2022

von Jin, Y. | Landon, J. | Krueger, W. | +3

4

Patient characteristics associated with use of TNF vs interleukin inhibitors as first-line biologic treatment for psoriatic arthritis

enthalten in: Journal of managed care & specialty pharmacy | 2021

von Jin, Y. | Chen, S. | Lee, H. | +3

5

Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease

enthalten in: The Journal of rheumatology | 2018

von Jin, Y. | Kang, E. | Brill, G. | +2

6

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus : A Multidatabase Cohort Study

enthalten in: Journal of the American Heart Association | 2018

von Kang, E. | Jin, Y. | Brill, G. | +4

7

Temporal Trends in Use of Biologic DMARDs for Rheumatoid Arthritis in the United States : A Cohort Study of Publicly and Privately Insured Patients

enthalten in: Journal of managed care & specialty pharmacy | 2017

von Desai, R. | Solomon, D. | Jin, Y. | +2

1
[1]